Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction
AssigneesLivaNova USA, Inc., East Tennessee State University
InventorsBruce H. KenKnight, Jeffrey L. Ardell, Imad Libbus, Badri Amurthur
Life of this patent
Estimating the term…
Abstract
Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.
Claims21
1-20. (canceled)
A method of operating an implantable medical device (IMD), the method comprising:
- generating a plurality of stimulation signals configured to stimulate a nerve of a patient, each stimulation signal of the plurality of stimulation signals having a duty cycle, a frequency, an amplitude, and a pulse width, wherein generating the plurality of stimulation signals comprises adjusting at least one of the duty cycle, the amplitude, or the pulse width while maintaining a fixed frequency across the plurality of stimulation signals;
- detecting a cardiac parameter response of the patient during the generation of the plurality of stimulation signals;
- identifying a range of the adjusted at least one of the duty cycle, the pulse width, or the amplitude that results in the cardiac parameter response being between a baseline cardiac parameter and a cardiac parameter decrease threshold;
- and
- delivering a plurality of stimulation signals at a duty cycle, a frequency, an amplitude, and a pulse width resulting in the cardiac parameter response being between the baseline cardiac parameter and the cardiac parameter decrease threshold.
An implantable medical device (IMD), comprising:
- a neurostimulator configured to deliver a stimulation signal to a nerve of a patient;
- and
- a control system programmed to:
- generate a plurality of stimulation signals configured to stimulate a nerve of a patient, each stimulation signal of the plurality of stimulation signals having a duty cycle, a frequency, an amplitude, and a pulse width, wherein control system is programmed to generate the plurality of stimulation signals by adjusting at least one of the duty cycle, the amplitude, or the pulse width while maintaining a fixed frequency across the plurality of stimulation signals;
- detect a cardiac parameter response of the patient during the generation of the plurality of stimulation signals;
- identify a range of the adjusted at least one of the duty cycle, the pulse width, or the amplitude that results in the cardiac parameter response being between a baseline cardiac parameter and a cardiac parameter decrease threshold;
- and
- deliver a plurality of stimulation signals at a duty cycle, a frequency, an amplitude, and a pulse width resulting in the cardiac parameter response being between the baseline cardiac parameter and the cardiac parameter decrease threshold.
Dependencies are inferred from the claim text.